Not all entrepreneurs look or act like Steve Jobs. Some get rich, but the vast majority do not; some have no interest in that at all. The common link for many of them is a desire to change the world, and there are many innovative ways to do so. This talk provides a look at the process of starting and building an organization, regardless of its business model, size, or ultimate goal, and also describes a few innovative thinkers who either have or will soon change the world via organizations they have started.
Dr. Judice is a co-founder of Cidara. Prior to launching Cidara, he served as an advisor to various investors and entrepreneurs, and served as the founding CEO of DiCE Molecules, Inc. in 2013. From 2004-2011, Dr. Judice was the founding CSO, and from 2007, the CEO at Achaogen, Inc. (Nasdaq: AKAO), a company dedicated to the discovery and development of antibiotics to treat serious infections caused by Gram-negative bacteria. Prior to Achaogen he oversaw the small molecule discovery group at Genentech, and before that he was the tenth employee at Theravance, Inc (Nasdaq: THRX) where he led the discovery of Vibativ (telavancin), a marketed anti-MRSA antibiotic. Dr. Judice received his PhD in organic chemistry at UCLA, working under Nobel laureate D.J. Cram, and was an NIH postdoctoral fellow in the laboratories of Peter Schultz at Berkeley. In 2008, he was named a Henry Crown Fellow of the Aspen Institute and is a member of the Aspen Global Leadership Network.